Publikationen 2010 - Klinik und Poliklinik für Chirurgie

Chirurgische Klinik und Poliklinik
der Technischen Universität München
(Direktor: Univ.-Prof. Dr. H. Friess)
Stand: 22.07.2014
Publikationen 2010
1.
Abiatari I, Esposito I, Oliveira TD, Felix K, Xin H, Penzel R, Giese T, Friess H, Kleeff
J. Moesin-dependent cytoskeleton remodelling is associated with an anaplastic
phenotype of pancreatic cancer. J Cell Mol Med 2010; 14(5): 1166-1179
2.
Al-Chalabi A, Matevossian E, Preibetael A, Perren A, Yang Z, Schuster T, Schreiber
C, Schimmel P, Nairz E, Yan H, Geiger A, Kreymann B. A Model of Ischemic Isolated
Acute Liver Failure in Pigs: Standardizing Monitoring and Treatment. Eur Surg Res
2010; 45(2): 86-97
3.
Altmayr F, Jusek G, Holzmann B. The neuropeptide CGRP causes repression of
TNF{alpha} transcription and suppression of ATF-2 promoter recruitment in Toll-like
receptor-stimulated dendritic cells. J Biol Chem 2010; 285(6): 3525-3531
4.
Aßfalg V, Hüser N, Reim D, Kaiser-Moore S, Rossmann-Bloeck T, Weighardt H,
Novotny AR, Stangl MJ, Holzmann B, Emmanuel KL. Combined immunosuppressive
and antibiotic therapy improves bacterial clearance and survival of polymicrobial
septic peritonitis. Shock 2010; 33(2): 155-161
5.
Balkow S, Heinz S, Schmidbauer P, Kolanus W, Holzmann B, Grabbe S, Laschinger
M. LFA-1 activity state on dendritic cells regulates contact duration with T cells and
promotes T-cell priming. Blood 2010; 16(11): 1885-1894
6.
Balluff B, Elsner M, Kowarsch A, Rauser S, Meding S, Schuhmacher C, Feith M,
Herrmann K, Rocken C, Schmid RM, Hofler H, Walch A, Ebert MP. Classification of
HER2/neu Status in Gastric Cancer Using a Breast-Cancer Derived Proteome
Classifier. J Proteome Res 2010; 9(12): 6317-6322
7.
Bartels H, Bogdanski R. Tracheotomie,
Viszeralchirurgie up2date 2010; 4(5): 297-312
8.
Blum T, Feussner H, Navab N. Modeling and segmentation of surgical workflow from
laparoscopic video. Med Image Comput Comput Assist Interv 2010; 13(Pt 3): 400407
9.
Brauer RB, Bodics R, Holak K, Genzel-Boroviczény O. Bood Doc, Bad Doc.
Bayerisches Ärzteblatt 2010; 65(11): 528-629
Tracheostomie.
Allgemein-
und
10. Brauer RB, Marx T, Ulm K, Stangl MJ. Effect of perioperative administration of a drug
regimen on the primary function of human renal allografts. Transplant Proc 2010;
42(5): 1523-1525
11. Brauer RB, Harnoss JC, Lang J, Harnoss J, Raschke R, Flemming S, Obertacke U,
Heidecke CD, Busemann A. Quality and Quality Assurance of Teaching in Surgery Recommendations from a Workshop of The Surgical Cooperative for Quality
Assurance. Zentralbl Chir 2010; 135(1): 18-24
Chirurgische Klinik und Poliklinik der TUM
12. Ceyhan GO, Demir IE, Maak M, Friess H. Fate of nerves in chronic pancreatitis:
Neural remodeling and pancreatic neuropathy. Best Pract Res Clin Gastroenterol
2010; 24(3): 311-322
13. Ceyhan GO, Schafer KH, Kerscher AG, Rauch U, Demir IE, Kadihasanoglu M, Bohm
C, Muller MW, Buchler MW, Giese NA, Erkan M, Friess H. Nerve Growth Factor and
Artemin Are Paracrine Mediators of Pancreatic Neuropathy in Pancreatic
Adenocarcinoma. Ann Surg 2010; 251(5): 923-931
14. Ceyhan GO, Liebl F, Maak M, Schuster T, Becker K, Langer R, Demir IE, Hartel M,
Friess H, Rosenberg R. The severity of neural invasion is a crucial prognostic factor
in rectal cancer independent of neoadjuvant radiochemotherapy. Ann Surg 2010;
252(5): 797-804
15. D'Haese JG, Demir IE, Friess H, Ceyhan GO. Fractalkine/CX3CR1: why a single
chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin
Ther Targets 2010; 14(2): 207-219
16. Dambrauskas Z, Giese N, Gulbinas A, Giese T, Berberat PO, Pundzius J, Barauskas
G, Friess H. Different profiles of cytokine expression during mild and severe acute
pancreatitis. World J Gastroenterol 2010; 16(15): 1845-1853
17. Demir IE, Ceyhan GO, Liebl F, D'Haese JG, Maak M, Friess H. Neural Invasion in
Pancreatic Cancer: The Past, Present and Future. Cancers (Basel) 2010; 2(3): 15131527
18. Demir IE, Ceyhan GO, Rauch U, Altintas B, Klotz M, Muller MW, Buchler MW, Friess
H, Schafer KH. The microenvironment in chronic pancreatitis and pancreatic cancer
induces neuronal plasticity. Neurogastroenterol Motil 2010; 22(4): 480-490
19. Doll D, Keller L, Maak M, Boulesteix AL, Siewert JR, Holzmann B, Janssen KP.
Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon
cancer and their impact on metastatic disease and survival. Int J Colorectal Dis 2010;
25(5): 573-581
20. Edling CE, Selvaggi F, Buus R, Maffucci T, Di SP, Friess H, Innocenti P, Kocher HM,
Falasca M. Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer.
Clin Cancer Res 2010; 16(20): 4928-4937
21. Ehnert S, Knobeloch D, Blankenstein A, Muller A, Bocker U, Gillen S, Friess H,
Thasler WE, Dooley S, Nussler AK. NeoHepatocytes From Alcoholics and Controls
Express Hepatocyte Markers and Display Reduced Fibrogenic TGF-beta/Smad3
Signaling: Advantage for Cell Transplantation? Alcohol Clin Exp Res 2010; 34(4):
708-718
22. Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese
NA, Ansorge W, Debus J, Huber PE, Friess H, Abdollahi A, Kleeff J. Organ-,
inflammation- and cancer specific transcriptional fingerprints of pancreatic and
hepatic stellate cells. Mol Cancer 2010; 9(1): 88
2
Chirurgische Klinik und Poliklinik der TUM
23. Erkan M, Reiser-Erkan C, Michalski CW, Kleeff J. Tumor microenvironment and
progression of pancreatic cancer. Exp Oncol 2010; 32(3): 128-131
24. Feussner H, Can S, Fiolka A, Schneider A, Wilhelm D. [Efficiency, risks, and
advantages of using robotic support systems in interventional medicine.].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53(8): 831838
25. Feussner H, Wilhelm D, Fiolka A, Friess H, Schneider A. NOTES über den
transsigmoidalen Zugang. Chirurg 2010; 81 418-425
26. Fiolka A, Gillen S, Meining A, Feussner H. ELITE--the ex vivo training unit for
NOTES: development and validation. Minim Invasive Ther Allied Technol 2010; 19(5):
281-286
27. Friederichs J, Von Weyhern CW, Rosenberg R, Doll D, Busch R, Lordick F, Siewert
JR, Sarbia M. Immunohistochemical detection of receptor tyrosine kinases c-kit, EGFR, and PDGF-R in colorectal adenocarcinomas. Langenbecks Arch Surg 2010;
395(4): 373-379
28. Friess H, Rosenberg R, Nitsche U. Book Reviews. Pancreatology 2010; 10(4): 503504
29. Friess H, Rosenberg R, Nitsche U. Book reviews: Practical Patient Safety.
Pancreatology 2010; 10 503-504
30. Gaida MM, Haag N, Gunther F, Tschaharganeh DF, Schirmacher P, Friess H, Giese
NA, Schmidt J, Wente MN. Expression of A disintegrin and metalloprotease 10 in
pancreatic carcinoma. Int J Mol Med 2010; 26(2): 281-288
31. Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B. TRIF Signaling
Stimulates Translation of TNF-{alpha} mRNA via Prolonged Activation of MK2. J
Immunol 2010; 184(10): 5842-5848
32. Gillen S, Fiolka A, Schneider A, Kranzfelder M, Feith M, Feussner H. ELITE: Das
neue hochimmersive Trainings- und Simulationssystem für NOTES. J Gastroenterol
Hepatol Erkr 2010; 8(2): 12-16
33. Gillen S, Kleeff J, Kranzfelder M, Shrikhande SV, Friess H, Feussner H. Natural
orifice transluminal endoscopic surgery in pancreatic diseases. World J Gastroenterol
2010; 16(31): 3859-3864
34. Gillen S, Friess H, Kleeff J. Präoperative/neoadjuvante Therapie beim
Pankreaskarzinom – Übersicht von Therapieansprechen, Resektionsraten und
Überleben. J Onkologie 2010; 5 22-24
35. Gillen S, Schuster T, Meyer Zum BC, Friess H, Kleeff J. Preoperative/neoadjuvant
therapy in pancreatic cancer: a systematic review and meta-analysis of response and
resection percentages. PLoS Med 2010; 7(4): e1000267
3
Chirurgische Klinik und Poliklinik der TUM
36. Gillen S, Michalski CW, Schuster T, Feith M, Friess H, Kleeff J.
Simultaneous/Incidental Cholecystectomy During Gastric/Esophageal Resection:
Systematic Analysis of Risks and Benefits. World J Surg 2010; 34(5): 1008-1014
37. Hac SA, Dobosz M, Nalecz A, Reszetow J, Dobrowolski S, Friess H, Michaljevic AL,
Mroczkowski P, Studniarek M, Sledzinski Z. Surgical Morphology of the Pancreatic
Isthmus. Pancreatology 2010; 10(2-3): 179-185
38. Hammer M, Echtenachter B, Weighardt H, Jozefowski K, Rose-John S, Mannel DN,
Holzmann B, Lang R. Increased inflammation and lethality of Dusp1(-/-) mice in
polymicrobial peritonitis models. Immunology 2010; 131(3): 395-404
39. Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M,
Becker K, Schuster T, Essler M, Wieder HA, Friess H, Ziegler SI, Schwaiger M,
Krause BJ. Comparison of Different SUV-Based Methods for Response Prediction to
Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer by FDG-PET
and MRI. Mol Imaging Biol 2010; 13(5): 1011-1019
40. Holler K, Schneider A, Jahn J, Gutierrez J, Wittenberg T, Feussner H, Hornegger J.
Spatial orientation in translumenal surgery. Minim Invasive Ther Allied Technol 2010;
19(5): 262-273
41. Hong X, Michalski CW, Kong B, Zhang W, Raggi MC, Sauliunaite D, De OT, Friess
H, Kleeff J. ALCAM is associated with chemoresistance and tumor cell adhesion in
pancreatic cancer. J Surg Oncol 2010; 101(7): 564-569
42. Höller K, Schneider A, Jahn J, Gutierrez J, Wittenberg T, Meining A, von DS,
Hornegger J, Feussner H. Orientierung endoskopischer Bilder: Rektifizierung durch
Schwerkraft. Biomed Tech (Berl) 2010; 55(4): 211-217
43. Huber W, Herrmann G, Schuster T, Phillip V, Saugel B, Schultheiss C, Hoellthaler J,
Gaa J, Hartel M, Schmid RM, Reindl W. [Life-threatening complications of Crohn's
disease and ulcerative colitis: a systematic analysis of admissions to an ICU during
18 years]. Dtsch Med Wochenschr 2010; 135(14): 668-674
44. Hüser N, Aßfalg V, Michalski CW, Gillen S, Kleeff J, Friess H. Das inoperable
Pankreaskarzinom - palliative interventionelle und chirurgische Therapie. Zentralbl
Chir 2010; 135(6): 502-507
45. Hüser N, Fasan A, Semmrich M, Schmidbauer P, Holzmann B, Laschinger M. Intact
LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft. Int
Immunol 2010; 22(1): 35-44
46. Jiang X, Gillen S, Esposito I, Giese NA, Michalski CW, Friess H, Kleeff J. Reduced
expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated
with worsened prognosis in pancreatic cancer. Histol Histopathol 2010; 25(12): 14971506
47. Kauer W, Rosenberg R, Friess H. Diagnostic and Therapeutic Standards in Patients
with Faecal Incontinence. German Medical Journal 2010; 10 24-32
4
Chirurgische Klinik und Poliklinik der TUM
48. Kong B, Michalski CW, Hong X, Valkovskaya N, Rieder S, Abiatari I, Streit S, Erkan
M, Esposito I, Friess H, Kleeff J. AZGP1 is a tumor suppressor in pancreatic cancer
inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-betamediated ERK signaling. Oncogene 2010; 29(37): 5146-5158
49. Kong B, Michalski CW, Friess H, Kleeff J. Surgical procedure as an inducer of tumor
angiogenesis. Exp Oncol 2010; 32(3): 186-189
50. Kranzfelder M, Büchler P, Lange K, Friess H. Treatment options for squamous cell
cancer of the esophagus: a systematic review of the literature. J Am Coll Surg 2010;
210(3): 351-359
51. Kunzli BM, Friess H, Shrikhande SV. Is laparoscopic colorectal cancer surgery equal
to open surgery? An evidence based perspective. World J Gastrointest Surg 2010;
2(4): 101-108
52. Langer R, Mutze K, Becker K, Feith M, Ott K, Hofler H, Keller G. Expression of class I
histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an
immunohistochemical study. J Clin Pathol 2010; 63(11): 994-998
53. Langer R, Becker K, Feith M, Friess H, Hofler H, Keller G. Genetic aberrations in
primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS
and BRAF in a series of 10 cases. Mod Pathol 2010; 24(4): 495-501
54. Langer R, Ott K, Feith M, Lordick F, Specht K, Becker K, Hofler H. High
pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with
nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma
patients. J Surg Oncol 2010; 102(5): 503-508
55. Lavoie EG, Fausther M, Kauffenstein G, Kukulski F, Kunzli BM, Friess H, Sevigny J.
Identification of the ectonucleotidases expressed in mouse, rat and human
Langerhans islets: Potential role of NTPDase3 in insulin secretion. Am J Physiol
Endocrinol Metab 2010; 299(4): E547-56E5
56. Liebermann-Meffert D. Rudolf Nissen (1896-1981)-perspective. J Gastrointest Surg
2010; 14 Suppl 1 S58-S61
57. Loos M, Hedderich DM, Friess H, Kleeff J. B7-h3 and its role in antitumor immunity.
Clin Dev Immunol 2010; 2010 online-first
58. Loos M, Künzli B, Friess H. Quantitation of CD39 Gene Expression in Pancreatic
Tissue by Real-Time Polymerase Chain Reaction. Methods Mol Biol 2010; 576 351362
59. Lorenzen S, Panzram B, Rosenberg R, Nekarda H, Becker K, Schenk U, Hofler H,
Siewert JR, Jager D, Ott K. Prognostic Significance of Free Peritoneal Tumor Cells in
the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with
Gastric Carcinoma Undergoing Potentially Curative Resection. Ann Surg Oncol 2010;
17(10): 2733-2739
5
Chirurgische Klinik und Poliklinik der TUM
60. Löhr JM, Faissner R, Koczan D, Bewerunge P, Bassi C, Brors B, Eils R, Frulloni L,
Funk A, Halangk W, Jesnowski R, Kaderali L, Kleeff J, Kruger B, Lerch MM, Losel R,
Magnani M, Neumaier M, Nittka S, Sahin-Toth M, Sanger J, Serafini S, Schnolzer M,
Thierse HJ, Wandschneider S, Zamboni G, Kloppel G. Autoantibodies Against the
Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression
Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the
Inflammatory Process. Am J Gastroenterol 2010; 105(9): 2060-2071
61. Ludwig L, Büchler P, Kleeff J, Gaa J, Stangl M, Prinz C, Langer R, Friess H, Schmid
RM, Algul H. Multidisciplinary Treatment of Aggressive and Rapidly Progressing
Biliary Papillomatosis. Dig Dis Sci 2010; 55(12): 3627-3629
62. Maak M, Nitsche U, Wert L, Shibayama M, Janssen KP, Friess H, Rosenberg R.
Rectal cancer: the impact of lymph node dissection and preoperative radiation in the
era of total mesorectal excision. Eur Surg 2010; 42(4): 159-163
63. Matevossian E, Aßfalg V, Novotny A, Reim D, Schmaderer Ch, Kern D, Nährig J, Doll
D, Hüser N. Adenoviral transfer in the liver: a novel in vivo simulation model in the rat.
Eur Surg 2010; 42(4): 177-179
64. Meining A, Feussner H. Lokale endoskopische Ablation von großen Adenomen und
Frühkarzinomen im Gastrointestinaltrakt – ESD, EMR oder Rendezvous?
Gastroenterologe 2010; 5(3): 238-244
65. Michalski CW, Erkan M, Friess H, Kleeff J. Tumor metabolism to blood flow ratio in
pancreatic cancer: helpful in patient stratification? Future Oncol 2010; 6(1): 13-15
66. Mihaljevic AL, Kleeff J, Friess H. Beger's operation and the Berne modification: origin
and current results. J Hepatobiliary Pancreat Surg 2010; 17(6): 735-744
67. Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Molecular mechanism of pancreatic
cancer-understanding proliferation, invasion, and metastasis. Langenbecks Arch
Surg 2010; 395(4): 295-308
68. Mutze K, Langer R, Becker K, Ott K, Novotny A, Luber B, Hapfelmeier A, Gottlicher
M, Hofler H, Keller G. Histone Deacetylase (HDAC) 1 and 2 Expression and
Chemotherapy in Gastric Cancer. Ann Surg Oncol 2010; 17(12): 3336-3343
69. Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D,
Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch
MM, Dervenis C, Olah A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH,
Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Buchler MW. Adjuvant
chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic
cancer resection: a randomized controlled trial. JAMA 2010; 304(10): 1073-1081
70. Nitsche U, Maak M, Rosenberg R, Friess H. Current standards in diverticular disease.
German Medical J 2010; 3 15-23
71. Novotny A, Matevossian E, Aßfalg V, Riediger C, Umgelter A, Thorban S, Friess H,
Büchler P. Lebertransplantation und kombinierte Nieren-Pankreas-Transplantation.
Nephrologe 2010; 5(2): 118-125
6
Chirurgische Klinik und Poliklinik der TUM
72. Novotny AR. Biomarkers in SIRS and sepsis: Quo vadis? J Emerg Trauma Shock
2010; 3(1): 36-38
73. Novotny
AR.
Kolorektales
Karzinom:
Überlebensrate. Gastro-News 2010; 4 2-3
Lebermetastasenresektion
steigert
74. Raggi M, Langer R, Feith M, Friess H, Schauer M, Theisen J. Successful evaluation
of a new animal model using mice for esophageal adenocarcinoma. Langenbecks
Arch Surg 2010; 395(4): 347-350
75. Raggi MC, Siebert SB, Steimer W, Schuster T, Stangl MJ, Abendroth DK.
Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate
Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal
Transplantation. Transplantation 2010; 90(12): 1536-1541
76. Raggi MC, Siebert SB, Abendroth DK, Steimer W, Friess H, Thorban SG. Neither
Mycophenolate Acyl-Glucuronide Levels nor Their Areas Under the Curve Are
Responsible for the Gastrointestinal Side Effects in Kidney Transplant Recipients
Receiving EC-MPA: A Prospective Trial. Transplant Proc 2010; 42(10): 4049-4052
77. Rauser S, Langer R, Tschernitz S, Gais P, Jutting U, Feith M, Hofler H, Walch A.
High number of CD45RO+ tumor infiltrating lymphocytes is an independent
prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.
BMC Cancer 2010; 10 608
78. Reim D. Invited commentary on: "The extent of lymph node dissection for gastric
cancer: A critical appraisal by eelco de bee, Vasilis charalampakis, John Melissas,
Dimitris D. Tsiftsis". J Surg Oncol 2010; 102(6): 551
79. Reim D, Hüser N, Humberg D, Novotny A, Aßfalg V, Matevossian E, Friess H,
Schuhmacher C. Preoperative clinically inapparent leucopenia in patients undergoing
neoadjuvant chemotherapy for locally advanced gastric cancer is not a risk factor for
surgical or general postoperative complications. J Surg Oncol 2010; 102(4): 321-324
80. Reiser-Erkan C, Erkan M, Ulbrich E, Nahrig J, Kleeff J. Cystic colon duplication
causing intussusception in a 25-year-old man: report of a case and review of the
literature. BMC Surg 2010; 10(1): 19
81. Rieder S, Michalski CW, Friess H. Indications for endoscopic or surgical treatment of
chronic pancreatitis. Dig Dis 2010; 28(2): 344-349
82. Rieder S, Bruse CS, Michalski CW, Kleeff J, Friess H. The impact factor ranking-a
challenge for scientists and publishers. Langenbecks Arch Surg 2010; 395(Supp.1):
57-61
83. Riediger C, Maak M, Sauter B, Friess H, Rosenberg R. Surgical management of
medicamentous, uncontrollable biliary reflux after esophagectomy and gastric pull-up.
Eur J Surg Oncol 2010; 36(7): 705-707
7
Chirurgische Klinik und Poliklinik der TUM
84. Riediger C, Muller MW, Michalski CW, Hüser N, Schuster T, Kleeff J, Friess H. TTube or no T-tube in the reconstruction of the biliary tract during orthotopic liver
transplantation: systematic review and meta-analysis. Liver Transpl 2010; 16(6): 705717
85. Rosenberg R, Nittka S. Aktualisierte UICC-Klassifikation: Genauere KolonkarzinomPrognose mit zwei Parametern. Gastro-News 2010; 2 2-3
86. Rosenberg R, Maak M, Schuster T, Becker K, Friess H, Gertler R. Does a rectal
cancer of the upper third behave more like a colon or a rectal cancer? Dis Colon
Rectum 2010; 53(5): 761-770
87. Rosenberg R, Maak M, Nitsche U, Shibayama M, Janssen KP, Friess H.
Lymphadenectomy in colorectal cancer: does it make a difference? Eur Surg 2010;
42(1): 8-11
88. Rosenberg R, Friess H. Should total number of lymph nodes be used as a quality of
care measure for stage III colon cancer? Ann Surg 2010; 251(1): 183-185
89. Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, Kopp R,
Putterich E, Ruppert R, Schuster T, Friess H, Holzel D. The prognostic value of lymph
node ratio in a population-based collective of colorectal cancer patients. Ann Surg
2010; 251(6): 1070-1078
90. Schauer M, Janssen KP, Rimkus C, Raggi M, Feith M, Friess H, Theisen J.
Microarray-based response prediction in esophageal adenocarcinoma. Clin Cancer
Res 2010; 16(1): 330-337
91. Schauer M, Theisen J. The diagnostic challenge of mediastinal sarcoidosis
accompanying esophageal cancer. World J Surg Oncol 2010; 8(1): 15
92. Schauer MC, Holzmann B, Peiper M, Friess H, Knoefel WT, Theisen J. Interleukin-10
and -12 Predict Chemotherapy-Associated Toxicity in Esophageal Adenocarcinoma.
J Thorac Oncol 2010; 5(11): 1849-1854
93. Schenck TL, Holzbach T, Zantl N, Schuhmacher C, Vogel M, Seidl S, Machens HG,
Giunta RE. Vaginal Carcinoma in a Female-to-Male Transsexual. J Sex Med 2010;
7(8): 2899-2902
94. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger
CF, Haag C, Mauer ME, Hasan B, Welch J, Ott K, Hoelscher A, Schneider PM,
Bechstein W, Wilke H, Lutz MP, Nordlinger B, Van CE, Siewert JR, Schlag PM.
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced
Cancer of the Stomach and Cardia: European Organisation for Research and
Treatment of Cancer Randomized Trial 40954. J Clin Oncol 2010; 28(35): 5210-5218
95. Seiler CM, Diener MK, Schuhmacher C. Bedeutung klinischer Studien für die
Chirurgie. Chirurg 2010; 81(4): 334-340
96. Sinicina I, Pankratz H, Bise K, Matevossian E. Forensic aspects of post-mortem
histological detection of amniotic fluid embolism. Int J Legal Med 2010; 124(1): 55-62
8
Chirurgische Klinik und Poliklinik der TUM
97. Sternfeld T, Spori-Byrtus V, Riediger C, Langer R, Friess H, Schmid RM, SchulteFrohlinde E. Acute measles infection triggering an episode of liver transplant
rejection. Int J Infect Dis 2010; 14(6): e528-e530
98. Stock KF, Klein BS, Vo Cong MT, Sarkar O, Romisch M, Regenbogen C, Buttner M,
Schuster T, Matevossian E, Amann K, Clevert DA, Heemann U, Kuchle C. ARFIbased tissue elasticity quantification in comparison to histology for the diagnosis of
renal transplant fibrosis. Clin Hemorheol Microcirc 2010; 46(2): 139-148
99. Su Y, Loos M, Giese N, Hines OJ, Diebold I, Gorlach A, Metzen E, Pastorekova S,
Friess H, Buchler P. PHD3 regulates differentiation, tumour growth and angiogenesis
in pancreatic cancer. Br J Cancer 2010; 103(10): 1571-1579
100. Vallon M, Rohde F, Janssen KP, Essler M. Tumor endothelial marker 5 expression in
endothelial cells during capillary morphogenesis is induced by the small GTPase Rac
and mediates contact inhibition of cell proliferation. Exp Cell Res 2010; 316(3): 412421
101. Vignali S, Peter N, Ceyhan G, Demir IE, Zeller F, Senseman D, Michel K, Schemann
M. Recordings from human myenteric neurons using voltage-sensitive dyes. J
Neurosci Methods 2010; 192(2): 240-248
102. von Delius S, Sager J, Feussner H, Wilhelm D, Thies P, Huber W, Schuster T,
Schneider A, Schmid RM, Meining A. Carbon dioxide versus room air for natural
orifice transluminal endoscopic surgery (NOTES) and comparison with standard
laparoscopic pneumoperitoneum. Gastrointest Endosc 2010; 72(1): 161-169
103. von Delius S, Wilhelm D, Feussner H, Sager J, Becker V, Schuster T, Schneider A,
Schmid RM, Meining A. Natural orifice transluminal endoscopic surgery:
cardiopulmonary safety of transesophageal mediastinoscopy. Endoscopy 2010;
42(5): 405-412
104. Wang W, Reiser-Erkan C, Michalski CW, Raggi MC, Quan L, Yupei Z, Friess H,
Erkan M, Kleeff J. Hypoxia inducible BHLHB2 is a novel and independent prognostic
marker in pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun 2010;
401(3): 422-428
105. Wilhelm D, Meining A, Schneider A, Delius SV, Preissel A, Sager J, Fiolka A, Friess
H, Feussner H. NOTES for the cardia: antireflux therapy via transluminal access.
Endoscopy 2010; 42(12): 1085-1091
106. Wilhelm D, von Delius S, Meining A, Feussner H. Reply to: doi:10.1007/s00464-0090668-z: Combined laparoscopic-endoscopic resection of colorectal polyps: 10-year
experience and follow-up evaluation. Surg Endosc 2010; 24(3): 733-634
107. Zhivkova-Galunska M, Adwan H, Eyol E, Kleeff J, Kolb A, Bergmann F, Berger MR.
Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer
cell lines. Cancer Biol Ther 2010; 10(1): 54-64
9
Chirurgische Klinik und Poliklinik der TUM
108. Zhu ZL, Zhao ZR, Zhang Y, Yang YH, Wang ZM, Cui DS, Wang MW, Kleeff J, Kayed
H, Yan BY, Sun XF. Expression and significance of FXYD-3 protein in gastric
adenocarcinoma. Dis Markers 2010; 28(2): 63-69
Bücher und Buchbeiträge
1.
Bartels H. Pathophysiologische Folgen, Vorbehandlung und Nachbehandlung bei
operativen Eingriffen und Traumaen. In: Siewert JR, Brauer RB (eds) Basiswissen
Chirurgie. Springer Verlag, Berlin, Heidelberg, New York, 2010, pp 16-22
2.
Bartels H. Präoperative Risikoabschätzung. In: Siewert JR, Rothmund M,
Schumpelick V (eds) Praxis der Viszeralchirurgie. Springer Verlag, Berlin,
Heidelberg, New York, 2010, pp 242-248
3.
Bruns CJ, Assmann G, Belka C, Fuchs M, Heinemann V, Kleeff J, Schlesinger-Raab
A, Wagner A, Wilkowski R, Friess H. Karzinome des exokrinen Pankreas und der
periampullären Region. In: Bruns CJ (ed) Manual Gastrointestinale Tumoren Empfehlungen zur Diagnostik, Therapie und Nachsorge. W. Zuckschwerdt Verlag,
München, 2010, pp 94-118
4.
Doll D, Matevossian E, Hoffmann S, Stettbacher A. Stichverletzungen. In: Wölfl Ch,
Matthes G (eds) Unfallrettung - Einsatztaktik, Technik und Rettungsmittel. Schattauer
GmbH, Stuttgart, 2010, pp 150-157
5.
Schäfer C, Rittler P, Martignoni ME, Schoenberg MH, Jauch KW. Ernährung bei
gastrointestinalen
Tumoren
und
therapiebedingten
gastrointestinalen
Nebenwirkungen. In: Bruns CJ (ed) Manual Gastrointestinale Tumoren Empfehlungen zur Diagnostik, Therapie und Nachsorge. W. Zuckschwerdt Verlag,
München, 2010, pp 283-291
6.
Schmid RM, Kleeff J, Helmberger H, Fuchs M, Schlesinger-Raab A, Sackmann H,
Assmann G, Boeck S, Schäfer C. Gallenblasen- und Gallengangskarzinome. In:
Bruns CJ (ed) Manual Gastrointestinale Tumoren - Empfehlungen zur Diagnostik,
Therapie und Nachsorge. W. Zuckschwerdt Verlag, München, 2010, pp 119-130
7.
Siewert JR, Brauer RB (2010) Basiswissen Chirurgie. Springer Verlag, Berlin,
Heidelberg, New York, 2010
10